Neurological Diseases

News Neurological Diseases

• Gladstone scientists reprogram skin cells into brain cells

  Scientists at the Gladstone Institutes have for the first time transformed skin cells — with a single genetic factor — into cells that develop on their own into an interconnected, functional network of brain cells. The research offers new hope in the fight against many neurological conditions becaus more

• Evotec announces multi-target collaboration with UCB in neurodegenerative and neurological diseases

  Evotec AG announced that it has entered into a three year integrated drug discovery collaboration with UCB to identify small molecule modulators of priority biological targets, selected by UCB, involved in CNS disorders. As part of the collaboration, Evotec will apply their integrated drug discovery more

• Mayo Clinic finds new genetic cause of neurodegeneration

  Mayo Clinic researchers have discovered two mutations responsible for a devastating neurological condition they first identified 15 years ago. The researchers say their study - appearing in Nature Genetics - has revealed a new neural pathway that may help understand a variety of similar conditions." more

Publications Neurological Diseases

• Human alpha‐ and beta‐NRXN1 isoforms rescue behavioral impairments of C. elegans neurexin‐deficient mutants

  Abstract Neurexins are cell adhesion proteins that interact with neuroligin and other ligands at the synapse. In humans, mutations in neurexin or neuroligin genes have been associated with autism and other mental disorders. The human neurexin and neuroligin genes are orthologous to the C. elegan more

• Global gene expression analysis of amniotic fluid cell‐free RNA from recipient twins with twin‐twin transfusion syndrome

  ABSTRACT Objective To understand the biological pathways involved in twin‐twin transfusion syndrome (TTTS) by performing global gene expression analysis of amniotic fluid (AF) cell‐free RNA. Methods Prospective whole transcriptome microarray study analyzing cell‐free RNA in AF from TTTS more

• Identification of extracellular miRNA in human cerebrospinal fluid by next-generation sequencing [METHOD]

  There has been a growing interest in using next-generation sequencing (NGS) to profile extracellular small RNAs from the blood and cerebrospinal fluid (CSF) of patients with neurological diseases, CNS tumors, or traumatic brain injury for biomarker discovery. Small sample volumes and samples with l more

Market studies Neurological Diseases

• BrainStorm Cell Therapeutics Inc. (BCLI) - Financial and Strategic SWOT Analysis Review

  BrainStorm Cell Therapeutics Inc. (BrainStorm) is a publicly held company that is engaged in developing stem cell technologies to provide treatments for incurable neurodegenerative diseases. The company develops its core technology NurOwn for autologous transplantation into patients with neurologica more

• Memory Pharmaceuticals Corp. - Strategic SWOT Analysis Review

  Memory Pharmaceuticals Corp. (Memory Pharmaceutical) is a biopharmaceutical company, engaged in the discovery and development of drug candidates for the treatment of central nervous system (CNS) disorders. The company develops new therapies for neurological diseases such as Alzheimer’s disease, bipo more

• Prana Biotechnology Limited (PBT) - Financial and Strategic SWOT Analysis Review

  Prana Biotechnology Limited (Prana Biotechnology) is a publicly held company engaged in development of stage biotechnology, research and development of therapeutic drugs for neurological diseases. The focus of the company lies on the areas of Alzheimer‘s, Parkinson‘s, and Huntington‘s diseases, as w more

Websites Neurological Diseases